SpletNDA 022445 provides for the use of Sustol (granisetron) extended-release injection, for subcutaneous use, we have designated as follows: (b) (4) NDA 022445/Original 1 - … Splet5.50.15 Section: Prescription Drugs Effective Date: January 1, 2024 Subsection: Gastrointestinal Agents Original Policy Date: April 20, 2024 Subject: 5-HT3 Antagonists Page: 3 of 6 3. Post-operative nausea and/or vomiting a. Operation was within the last month 4. Zofran and Zuplenz only: Nausea and/or vomiting of pregnancy (NVP) a.
Compare Sustol vs Granisetron - Iodine.com
SpletSustol [package insert]. San Diego, CA; Heron Therapeutics; May 2024. Accessed February 2024. 2. Schnadig ID, Agajanian R, Dakhil C, et al. APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in … SpletSustol Extended-Release Injection 10 mg/0.4 mL syringe: 1 syringe per 7 day supply B. Max Units (per dose and over time) [HCPCS Unit]: 100 billable units per 7 days III. Initial … grown treatment
News Release Details - Heron Therapeutics
SpletSUSTOL® (granisetron extended-release) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without approval. ©2024, Magellan Rx Management VII. References 1. Sustol [package insert]. San Diego, CA; Heron Therapeutics; May 2024. Accessed March 2024. 2. Schnadig ID, Agajanian R, Dakhil C, et al. APF530 ... SpletSustol (granisetron) is a long-acting injection that helps to prevent nausea and vomiting due to cancer chemotherapies, but causes bleeding and bruising at the injection site. ... The Sustol (granisetron) FDA package insert doesn’t have numbers about how common side effects are. 6 possible side effects. Headache. 20 % Weakness. 18 % ... SpletUsual Dosage: See package insert. Storage: See package insert. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Prior to intravenous infusion, Tre-prostinil … filtercopy thoughts